Veterinary vaccines found to combine into new viruses, prompting regulatory response

July 12, 2012
Vaccines combine to produce new virus strain. Credit: Australian Science Media Centre

Research from the University of Melbourne has shown that two different vaccine viruses- used simultaneously to control the same condition in chickens- have combined to produce new infectious viruses, prompting early response from Australia's veterinary medicines regulator.

The vaccines were used to control infectious laryngotracheitis (ILT), an acute respiratory disease occurring in chickens worldwide. ILT can have up to 20% mortality rate in some flocks and has a significant economic and welfare impact in the .

The research found that when two different ILT strains were used in the same populations, they combined into two new strains (a process known as recombination), resulting in disease outbreaks.

Neither the ILT or the new strains can be transmitted to humans or other animals, and do not pose a food safety risk.

The study was led by Dr Joanne Devlin, Professor Glenn Browning and Dr Sang-Won Lee and colleagues at the Asia-Pacific Centre for Animal Health at the University of Melbourne and NICTA's Victoria Research Laboratory and is published today in the journal Science.

Dr Devlin said the combining of live vaccine outside of the laboratory was previously thought to be highly unlikely, but this study shows that it is possible and has led to disease outbreaks in .

"We alerted the Australian Pesticide and Veterinary Medicines Authority (APVMA) to our findings and they are now working closely with our research team, vaccine registrants and the poultry industry to determine both short and long term regulatory actions," she said.

"Short-term measures include risk assessment of all live virus vaccines currently registered by the APVMA in regard to the risk of recombination and could include changes to , which may result in restrictions on the use of two vaccines of different origins in the one ."

The ILT vaccines are 'live attenuated vaccines', which means that the virus has some disease-causing factors removed but the immune system still recognises the virus to defend against a real infection.

"Live vaccines are used throughout the world to control ILT in poultry. For over 40 years the vaccines used in Australia were derived from an Australian virus strain. But following a vaccine shortage another vaccine originating from Europe was registered in 2006 and rapidly became widely used," Dr Devlin said.

"Shortly after the introduction of the European strain of vaccine, two new strains of ILT virus were found to be responsible for most of the outbreaks of disease in New South Wales and Victoria. So we sought to examine the origin of these two new strains."

The team sequenced all of the genes (the genome) of the two vaccines used in Australia, and the two new outbreak strains of the virus. Following bioinformatic analysis on the resulting DNA sequence, in conjunction with Dr John Markham at NICTA's Victoria Research Laboratory, they found that the new disease-causing strains were combinations of the Australian and European origin vaccine strains.

"Comparisons of the vaccine strains and the new recombinant strains have shown that both the recombinant strains cause more severe disease, or replicate to a higher level than the parent vaccine strains that gave rise to them," Dr Lee said.

Professor Glenn Browning said recombination was a natural process that can occur when two viruses infect the same cell at the same time.

"While recombination has been recognised as a potential risk associated with live virus vaccines for many years, the likelihood of it happening in viruses like this in the field has been thought to be so low that it was considered to be very unlikely to lead to significant problems," he said.

"Our studies have shown that the risk of recombination between different in the field is significant as two different recombinant viruses arose within a year. We also demonstrated that the consequences of such recombination can be very severe, as the new viruses have been responsible for the deaths of thousands of Australian poultry."

"The study suggests that regulation of live attenuated vaccines for all species needs to take into account the real potential for vaccine viruses to combine. Measures such as those now being taken for the ILT vaccines will need to be implemented."

Explore further: Study: Live H5N1 virus vaccines effective

More information: "Attenuated Vaccines Can Recombine to Form Virulent Field Viruses," by S.-W. Lee et al , Science, 2012.

Related Stories

Study: Live H5N1 virus vaccines effective

September 12, 2006

U.S. scientists say live, weakened versions of differing strains of avian flu viruses have offered protection when tested in mice and ferrets.

New fowlpox vaccine available

October 26, 2007

A new vaccine developed by CSIRO Livestock Industries to help control the common poultry disease, fowlpox, has been registered for commercial use by one of Australia’s leading animal health companies, Intervet Australia ...

Study: Flu shot better than nasal spray in adults

September 23, 2009

( -- A flu shot is 50 percent more effective than nasal spray vaccine in preventing seasonal influenza in healthy adults, a new University of Michigan study shows.

Recommended for you

Study suggests fish can experience 'emotional fever'

November 25, 2015

(—A small team of researchers from the U.K. and Spain has found via lab study that at least one type of fish is capable of experiencing 'emotional fever,' which suggests it may qualify as a sentient being. In their ...

A huge chunk of a tardigrade's genome comes from foreign DNA

November 23, 2015

Researchers from the University of North Carolina at Chapel Hill have sequenced the genome of the nearly indestructible tardigrade, the only animal known to survive the extreme environment of outer space, and found something ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.